SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
50 hedge funds and large institutions have $139M invested in SQZ Biotechnologies Company in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
14% more funds holding
Funds holding: 44 → 50 (+6)
30% less capital invested
Capital invested by funds: $199M → $139M (-$59.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.01M |
| 2 |
6CM
683 Capital Management
New York
|
+$1.96M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$545K |
| 4 |
State Street
Boston,
Massachusetts
|
+$287K |
| 5 |
Two Sigma Advisers
New York
|
+$228K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.36M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$514K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$273K |
| 4 |
SG Americas Securities
New York
|
-$195K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$137K |
SQZ Hedge Fund Activity: Q4 2021 in Review
50 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q4 2021, worth a combined $139M — down 30% from $199M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SQZ positions and 4 closed out — a net gain of 6 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $2.01M. The largest seller was JP Morgan Chase, cutting an estimated $1.36M.
- 50 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q4 2021, up from 44 in Q3 2021.
- Funds reported $139M of SQZ Biotechnologies Company stock for Q4 2021, down 30% quarter-over-quarter.
- 10 funds opened new SQZ Biotechnologies Company positions in Q4 2021 and 4 closed out, a net change of +6 holders.
- The largest SQZ Biotechnologies Company buyer in Q4 2021 was BlackRock, an estimated $2.01M added.
- The largest SQZ Biotechnologies Company seller in Q4 2021 was JP Morgan Chase, an estimated $1.36M sold.
Based on aggregated 13F filings for Q4 2021.